Showing 61 - 80 results of 1,378 for search '"growth factors"', query time: 0.09s Refine Results
  1. 61

    Fibroblast Growth Factor and Mineral Metabolism Parameters among Prevalent Kidney Transplant Patients by Madhumathi Rao, Priyanka Jain, Temitope Ojo, Gautam Surya, Vaidyanathapuram Balakrishnan

    Published 2012-01-01
    “…Chronic kidney disease (CKD) related mineral bone disorders persist after kidney transplantation, but little is known about the relationship between fibroblast growth factor-23 (FGF-23) and mineral metabolism in prevalent post-transplant patients. …”
    Get full text
    Article
  2. 62
  3. 63
  4. 64

    Fibroblast Growth Factor 21 Deficiency Attenuates Experimental Colitis-Induced Adipose Tissue Lipolysis by Liming Liu, Cuiqing Zhao, Ying Yang, Xiaoxia Kong, Tuo Shao, Li Ren, Xinyu Zhuang, Baishuang Yin, Gerald Dryden, Craig McClain, Weimin Luan, Wenke Feng

    Published 2017-01-01
    “…Adipose tissue plays a critical role in regulating energy balance. Fibroblast growth factor 21 (FGF21) is an important endocrine metabolic regulator with emerging beneficial roles in lipid homeostasis. …”
    Get full text
    Article
  5. 65
  6. 66

    The Effect of Antivascular Endothelial Growth Factor on the Development of Adhesion Formation in Laparotomized Rats: Experimental Study by Murat Basbug, Nurullah Bulbuller, Cemalettin Camci, Refik Ayten, Erhan Aygen, Ibrahim Hanifi Ozercan, Zulfu Arikanoglu, Sami Akbulut

    Published 2011-01-01
    “…This study determined the effects of a single dose of bevacizumab, an antiangiogenic recombinant monoclonal antibody that specifically targets vascular endothelial growth factor (VEGF), on adhesion formation in the rat cecal abrasion model. …”
    Get full text
    Article
  7. 67
  8. 68
  9. 69

    Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy by Hui-Jin Chen, Zhi-Zhong Ma, Ying Li, Chang-Guan Wang

    Published 2019-01-01
    “…To study the change of concentrations of vascular endothelial growth factor (VEGF) in vitreous cavity after vitrectomy in eyes with proliferative diabetic retinopathy (PDR). …”
    Get full text
    Article
  10. 70

    Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs by Haitao Zhang, Xin Yang, Fangfang Zheng, Xiangke Yin, Suhua Wan

    Published 2022-01-01
    “…To explore clinical characteristics and treatment reasons for intravitreal injection of antivascular endothelial growth factor (anti-VEGF) drugs in the treatment of nontype 1 retinopathy of prematurity (ROP). …”
    Get full text
    Article
  11. 71

    The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease by Claude Messier, Kevin Teutenberg

    Published 2005-01-01
    “…Peripheral levels of Insulin Growth Factor-I (IGF-I) are associated with glucose regulation and influence glucose disposal. …”
    Get full text
    Article
  12. 72
  13. 73
  14. 74
  15. 75

    Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy by Byung Ju Jung, Mee Yon Lee, Sohee Jeon

    Published 2019-01-01
    “…This study is for identifying systemic factors correlating with intraocular levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in diabetic retinopathy. Forty-two consecutive patients undergoing pars plana vitrectomy (PPV) for PDR were included in this cross-sectional study. …”
    Get full text
    Article
  16. 76

    Glutathione S-Transferase Omega-2 and Transforming Growth Factor-β1 Polymorphisms in Iranian Glaucoma Patients by Shahram Bamdad, Fatemeh Sanie-Jahromi, Marzieh Alamolhoda, Nasrin Masihpour, Mohammad-Hossein Karimi

    Published 2021-01-01
    “…To investigate the association of glutathione s-transferase omega 2 (GSTO2) (142N > D) and transforming growth factor-β1 (TGF-β1) (869T > C) gene polymorphisms on the pathogenesis of two common types of glaucoma (including primary open-angle glaucoma (POAG) and chronic angle-closure glaucoma (CACG)) in the Iranian population. …”
    Get full text
    Article
  17. 77
  18. 78

    Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity by Xuting Chen, Lin Zhou, Qi Zhang, Yu Xu, Peiquan Zhao, Hongping Xia

    Published 2019-01-01
    “…Intravitreal injection of ranibizumab (IVR), an antivascular endothelial growth factor (VEGF) drug, showed significant benefit for ROP. …”
    Get full text
    Article
  19. 79
  20. 80